Document:

EX-4.10

 Exhibit 4.10 

THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 

SYNCARDIA SYSTEMS, INC. 

WARRANT TO PURCHASE SERIES E PREFERRED STOCK 
  

					
	No. PEW-    				            , 20    

 Void After             ,
20     
 THIS CERTIFIES THAT, for value
received,             , with its principal office at                     , or assigns
(the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from SYNCARDIA SYSTEMS, INC., a Delaware corporation, with its
principal office at 1992 East Silverlake Rd, Tucson, AZ 85713 (the “Company”) up to [            
(                )] shares of the Series E Preferred Stock of the Company (the “Preferred Stock”). 

Immediately prior to the closing of the Company’s initial public offering, this warrant shall become exercisable for that number of
shares of Common Stock of the Company into which the shares of Preferred Stock issuable under this warrant would then be convertible, so long as such shares, if this warrant has been exercised prior to such offering, would have been converted into
shares of the Company’s Common Stock pursuant to the automatic conversion provisions (or otherwise) of the Company’s Seventh Restated Certificate of Incorporation. 

This Warrant is issued pursuant to the terms of the Subscription Agreement, dated [date] by and among the Company and the Holder (the
“Subscription Agreement”). This Warrant is one of a series of warrants issued in connection with the offering of units (the “Series E Units”) pursuant to that certain Series E Confidential Private
Placement Memorandum dated October 27, 2010, with each Series E Unit consisting of one share of Preferred Stock (the “Series E Preferred Shares”) and a warrant to purchase one share of Preferred Stock (collectively, the
“Series E Warrants”). 
 1. DEFINITIONS. As used herein, the following terms shall have the
following respective meanings: 
 (a) “Exercise Period” shall mean the period commencing with
the date hereof and ending ten (10) years later, unless sooner terminated as provided below. 
 (b)
“Exercise Price” shall mean $6.15 per share, subject to adjustment pursuant to Section 5 below. 

(c) “Exercise Shares” shall mean the shares of the Company’s Preferred Stock issuable upon
exercise of this Warrant, subject to adjustment pursuant to the terms herein, including but not limited to adjustment pursuant to Section 5 below. 

  
 1. 

 2. EXERCISE OF WARRANT. The rights
represented by this Warrant may be exercised in whole or in part at any time during the Exercise Period, by delivery of the following to the Company at its address set forth above (or at such other address as it may designate by notice in writing to
the Holder): 
 (a) An executed Notice of Exercise in the form attached hereto; 

(b) Payment of the Exercise Price either (i) in cash or by check, or (ii) by cancellation of indebtedness; and 

(c) This Warrant. 

Upon the exercise of the rights represented by this Warrant, a certificate or certificates for the Exercise Shares so purchased, registered in
the name of the Holder or persons affiliated with the Holder, if the Holder so designates, shall be issued and delivered to the Holder within a reasonable time after the rights represented by this Warrant shall have been so exercised. 

The person in whose name any certificate or certificates for Exercise Shares are to be issued upon exercise of this Warrant shall be deemed to
have become the holder of record of such shares on the date on which this Warrant was surrendered and payment of the Exercise Price was made, irrespective of the date of delivery of such certificate or certificates, except that, if the date of such
surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are
open. 
 2.1 Net Exercise. Notwithstanding any provisions herein to the contrary, if the fair market value of one share of the
Company’s Preferred Stock is greater than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, the Holder may elect to receive shares equal to the value (as determined below)
of this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company shall issue to the Holder a number of
shares of Preferred Stock computed using the following formula: 
  

					
					 X = Y (A-B)

            A
  

	Where		X =    		the number of shares of Preferred Stock to be issued to the Holder
			
			Y =		the number of shares of Preferred Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such calculation)
			
			A =		the fair market value of one share of the Company’s Preferred Stock (at the date of such calculation)
			
			B =		Exercise Price (as adjusted to the date of such calculation)

  
 2. 

 For purposes of the above calculation, the fair market value of one share of Preferred Stock
shall be determined by the Company’s Board of Directors in good faith; provided, however, that in the event that this Warrant is exercised pursuant to this Section 2.1 in connection with the Company’s initial public offering of its
Common Stock, the fair market value per share shall be the product of (i) the per share offering price to the public of the Company’s initial public offering, and (ii) the number of shares of Common Stock into which each share of
Preferred Stock is convertible at the time of such exercise. 
 3. COVENANTS OF THE
COMPANY. 
 3.1 Covenants as to Exercise Shares. The Company covenants and agrees that all Exercise Shares that
may be issued upon the exercise of the rights represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The
Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized and reserved, free from preemptive rights, a sufficient number of shares of its Preferred Stock to provide for the exercise of the
rights represented by this Warrant. If at any time during the Exercise Period the number of authorized but unissued shares of Preferred Stock shall not be sufficient to permit exercise of this Warrant, the Company will take such corporate action as
may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Preferred Stock to such number of shares as shall be sufficient for such purposes. 

3.2 No Impairment. Except and to the extent as waived or consented to by the Holder, the Company will not, by amendment of its Seventh
Restated Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to
protect the exercise rights of the Holder against impairment. 
 3.3 Notices of Record Date. In the event of any taking by the
Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend which is the same as cash dividends paid in previous quarters) or
other distribution, the Company shall mail to the Holder, at least ten (10) days prior to the date specified herein, a notice specifying the date on which any such record is to be taken for the purpose of such dividend or distribution.

 4. REPRESENTATIONS OF HOLDER. 

4.1 Acquisition of Warrant for Personal Account. The Holder represents and warrants that it is acquiring the Warrant and the Exercise
Shares solely for its account for investment and not with a view to or for sale or distribution of said Warrant or Exercise Shares or any part thereof. The Holder also represents that the entire legal and beneficial interests of the Warrant and
Exercise Shares the Holder is acquiring is being acquired for, and will be held for, its account only. 

  
 3. 

 4.2 Securities Are Not Registered. 

(a) The Holder understands that the Warrant and the Exercise Shares have not been registered under the
Securities Act of 1933, as amended (the “Act”) on the basis that no distribution or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be present if,
notwithstanding its representations, the Holder has a present intention of acquiring the securities for a fixed or determinable period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or
otherwise distributing the securities. The Holder has no such present intention. 
 (b) The Holder recognizes that the
Warrant and the Exercise Shares must be held indefinitely unless they are subsequently registered under the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register the Warrant or
the Exercise Shares of the Company, or to comply with any exemption from such registration. 
 (c) The Holder is aware that
neither the Warrant nor the Exercise Shares may be sold pursuant to Rule 144 adopted under the Act unless certain conditions are met, including, among other things, the existence of a public market for the shares, the availability of certain current
public information about the Company, the resale following the required holding period under Rule 144 and the number of shares being sold during any three month period not exceeding specified limitations. Holder is aware that the conditions for
resale set forth in Rule 144 have not been satisfied and that the Company presently has no plans to satisfy these conditions in the foreseeable future. 

4.3 Legends. The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder may bear the
following legends: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A SIXTH AMENDED AND RESTATED
STOCKHOLDERS’ AGREEMENT, AS AMENDED FROM TIME TO TIME, AMONG THE ISSUER OF SUCH SECURITIES (THE “COMPANY”) AND CERTAIN OF THE COMPANY’S STOCKHOLDERS. A COPY OF SUCH STOCKHOLDERS’ AGREEMENT AND ANY AMENDMENTS THERETO WILL BE
FURNISHED WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF PROMPTLY UPON WRITTEN REQUEST.” 
 “THE SHARES REPRESENTED BY THE
WITHIN CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SHARES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.” 
 5.
ADJUSTMENT OF EXERCISE PRICE. In the event of changes in the outstanding Preferred Stock of the Company by reason of stock dividends, split-ups, recapitalizations,

  
 4. 

 
reclassifications, combinations or exchanges of shares, separations, reorganizations, liquidations, or the like, the number and class of shares available under the Warrant in the aggregate and
the Exercise Price shall be correspondingly adjusted to give the Holder of the Warrant, on exercise for the same aggregate Exercise Price, the total number, class, and kind of shares as the Holder would have owned had the Warrant been exercised
prior to the event and had the Holder continued to hold such shares until after the event requiring adjustment; provided, however, that such adjustment shall not be made with respect to, and this Warrant shall terminate if not exercised prior to,
the events set forth in Section 7 below. The form of this Warrant need not be changed because of any adjustment in the number of Exercise Shares subject to this Warrant. 

6. FRACTIONAL SHARES. No fractional shares shall be issued upon the exercise of this Warrant as a
consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the issuance of any fractional share.
If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product resulting
from multiplying the then current fair market value of an Exercise Share by such fraction. 
 7. EARLY
TERMINATION. In the event of, at any time during the Exercise Period, an initial public offering of securities of the Company registered under the Act, or any capital reorganization, or any reclassification of the capital stock of
the Company (other than a change in par value or from par value to no par value or no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of shares), or the consolidation or merger of the Company with or
into another corporation (other than a merger solely to effect a reincorporation of the Company into another state), or the sale or other disposition of all or substantially all the properties and assets of the Company in its entirety to any other
person, the Company shall provide to the Holder twenty (20) days advance written notice of such public offering, reorganization, reclassification, consolidation, merger or sale or other disposition of the Company’s assets, and this Warrant
shall terminate unless exercised prior to the date such public offering is closed or the occurrence of such reorganization, reclassification, consolidation, merger or sale or other disposition of the Company’s assets. 

8. MARKET STAND-OFF AGREEMENT. This Warrant and the Exercise Shares are
subject to the market stand-off agreement set forth in Section 7(k) of that certain Sixth Amended and Restated Stockholders’ Agreement, dated November 19, 2010, by and among the Company and the signatories thereto (the
“Stockholders’ Agreement”). 
 9. NO STOCKHOLDER
RIGHTS. This Warrant in and of itself shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. 

10. TRANSFER OF WARRANT. This Warrant and the Exercise Shares are subject to the terms and
conditions of the Stockholders’ Agreement, including the restrictions on transfer set forth in Section 3 therein, such that this Warrant and the Exercise Shares have the same restrictions on transfer as the Shares (as defined in the
Stockholders’ Agreement) are subject to in the Stockholders’ Agreement.  

  
 5. 

 11. LOST, STOLEN, MUTILATED OR
DESTROYED WARRANT. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant,
include the surrender thereof), issue a new Warrant of like denomination and tenor as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the
allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone. 
 12. NOTICES,
ETC. All notices required or permitted hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent
during normal business hours of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after
deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the Company at the address listed on the signature page and to Holder at
                     or at such other address as the Company or Holder may designate by ten (10) days advance written notice to the other
parties hereto. 
 13. ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and
agreement to all of the terms and conditions contained herein. 
 14. AMENDMENT. Any term of this Warrant may
be amended or waived with the written consent of the Company and the holders of a majority of the outstanding and unexercised Series E Warrants. Any such amendment shall be binding of all holders of Series E Warrants, including the Holder of this
Warrant, and shall be binding on their successors and assigns. 
 15. GOVERNING LAW. This
Warrant and all rights, obligations and liabilities hereunder shall be governed by the laws of the State of Arizona. 
 16.
COUNTERPARTS; FACSIMILE. This Warrant may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Facsimile and
electronic (i.e., PDF) signatures shall be as effective as original signatures. 

  
 6. 

 IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its duly authorized officer as of             , 20    . 

 

			
	SYNCARDIA SYSTEMS, INC.
		
	By:		  

		
	Name:		  

		
	Title:		  

		
	Address:		  

  
 7. 

 NOTICE OF EXERCISE 

TO: SYNCARDIA SYSTEMS, INC. 

(1)  ̈ The undersigned hereby elects to purchase
                 shares of the Series E Preferred Stock of SYNCARDIA SYSTEMS, INC. (the
“Company”) pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any. 

 ̈ The undersigned hereby elects to purchase
                 shares of the Series E Preferred Stock of SYNCARDIA SYSTEMS, INC. (the
“Company”) pursuant to the terms of the net exercise provisions set forth in Section 2.1 of the attached Warrant, and shall tender payment of all applicable transfer taxes, if any. 

(2) Please issue a certificate or certificates representing said shares of Series E Preferred Stock in the name of the undersigned or
in such other name as is specified below: 
  

							
	  
				  
		
	Name				Address		

 (3) The undersigned represents that (i) the aforesaid shares of Series E Preferred Stock are being
acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares; (ii) the
undersigned is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding its investment in the Company; (iii) the
undersigned is experienced in making investments of this type and has such knowledge and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment and protecting the
undersigned’s own interests; (iv) the undersigned understands that the shares of Series E Preferred Stock issuable upon exercise of this Warrant have not been registered under the Securities Act of 1933, as amended (the
“Securities Act”), by reason of a specific exemption from the registration provisions of the Securities Act, which exemption depends upon, among other things, the bona fide nature of the investment intent as expressed herein,
and, because such securities have not been registered under the Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available; and (v) the undersigned
is aware that the aforesaid shares of Series E Preferred Stock may not be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions are met and until the undersigned has held the shares for the number of years prescribed
by Rule 144, that among the conditions for use of the Rule is the availability of current information to the public about the Company and the Company has not made such information available and has no present plans to do so. 

 

					
	  
				  

	(Date)				(Signature)
			
					  

					(Print Name)EX-4.11

 Exhibit 4.11 

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A FORM REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE
FOREGOING, THIS WARRANT MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT. 
  

 

WARRANT TO PURCHASE COMMON STOCK 

 

			
	Warrant No.: CS-2015-7	  	Number of Warrant Shares: 35,971
	Warrant Exercise Price: $1.39	  	
	Date of Issuance: May 19, 2015	  	Expiration Date: As set forth in Section 1 below

 SynCardia Systems, Inc., a Delaware corporation (the “Company”), hereby certifies that, for Ten United States
Dollars ($10.00) and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Trinity SynCardia Bridge, LLC, an Arizona limited liability company (the “Holder”), the registered Holder
hereof or its permitted assigns, is entitled, subject to the terms set forth below, to purchase from the Company upon surrender of this Warrant, at any time or times on or after the Issuance Date, but not after 11:59 P.M. Eastern Time on the
Expiration Date (as defined in this Warrant) the number of fully paid and nonassessable shares of the Common Stock (as defined in this Warrant) of the Company (the “Warrant Shares”) set forth above at the exercise price per share
provided above or as subsequently adjusted. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the
Company’s most recent Form 10-QSB or Form 10-KSB, if any, (2) a more recent public announcement by the Company, or (3) any other notice by the Company or its transfer agent setting forth the number of shares of Common Stock
outstanding. Upon the written request of the Holder, the Company will promptly, but in no event later than two Business Days following the receipt of such notice, confirm in writing to any such Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock will be determined after giving effect to the exercise of Warrants (as defined below) by such Holder and its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. The Holder and the Company agree that this Warrant is exercisable at any time prior to the Expiration Date. This Warrant is being issued to Holder as an inducement to Holder to amend the promissory note
evidencing a loan the Company in the sum of $500,000 pursuant to the terms of that certain Loan Agreement, dated April 1, 2013. 

Section 1. 
 (a)
Definitions. The following words and terms as used in this Warrant will have the following meanings: 
 (i) “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized or required by law to remain closed. 

  
 1 

 (ii) “Expiration Date” means the earliest of (i) the date ten years from
the Issuance Date of this Warrant or, if such date falls on a Saturday, Sunday or other day on which banks are required or authorized to be closed in the City of Phoenix or the State of Arizona (a “Holiday”), the next date that is
not a Holiday; and (ii) the one (1) year anniversary of the consummation of the Company’s sale of its Common Stock or other capital stock pursuant to a registration statement under the Securities Act (other than a registration
statement relating either to sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a SEC Rule 145 transaction). 

(iii) “Issuance Date” means the date of this Warrant, which will for all purposes be the effective date of this Warrant.

 (iv) “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization and a government or any department or agency thereof. 
 (v) “Common Stock” means
(i) the Company’s Common Stock, par value $0.01 per share, and (ii) any capital stock into which such Common Stock will have been changed or any capital stock resulting from a reclassification of such Common Stock. 

(vi) “Securities Act” means the Securities Act of 1933, as amended. 

(vii) “Stockholders Agreement” means the Company’s Ninth Amended and Restated Stockholders’ Agreement dated as of
September 15, 2014, as amended subsequent to the date hereof. 
 (viii) “Warrant” means this Warrant and all Warrants
issued in exchange, transfer or replacement thereof. 
 (ix) “Warrant Exercise Price” will be the price set forth on page
one of this Warrant or as subsequently adjusted as provided in Section 8 hereof. 
 (x) “Warrant Shares” means
the shares of Common Stock issuable at any time upon exercise of this Warrant. 
 (b) Other Definitional Provisions. 

(i) Except as otherwise specified in this Warrant, all references in this Warrant (A) to the Company will be deemed to include the
Company’s successors and (B) to any applicable law defined or referred to in this Warrant will be deemed references to such applicable law as the same may have been or may be amended or supplemented from time to time. 

(ii) When used in this Warrant, the words “in this Warrant”, “hereof”, and “hereunder” and
words of similar import, will refer to this Warrant as a whole and not to any provision of this Warrant, and the words “Section”, “Schedule”, and “Exhibit” will refer to Sections of, and Schedules
and Exhibits to, this Warrant unless otherwise specified. 
 (iii) Whenever the context so requires, the neuter gender includes the
masculine or feminine, and the singular number includes the plural, and vice versa. 
 Section 2. Exercise of Warrant. 

  
 2 

 (a) Subject to the terms and conditions of this Warrant, this Warrant may be exercised by the
Holder then registered on the books of the Company, pro rata as hereinafter provided, at any time on any Business Day on or after the opening of business on such Business Day, commencing with the Issuance Date, and prior to 11:59 P.M. Eastern Time
on the Expiration Date, by (i) delivery of a written notice, in the form of the subscription notice attached as Exhibit A hereto (the “Exercise Notice”), of such Holder’s election to exercise this Warrant, which
notice will specify the number of Warrant Shares to be purchased, (ii) payment to the Company of an amount equal to the Warrant Exercise Price(s) applicable to the Warrant Shares being purchased, multiplied by the number of Warrant Shares (at
the applicable Warrant Exercise Price) as to which this Warrant is being exercised (plus any applicable issue or transfer taxes) (the “Aggregate Exercise Price”) in cash or wire transfer of immediately available funds and
(iii) the surrender of this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction) to a common carrier for overnight delivery to the Company as soon as practicable following such
date. In the event of any exercise of the rights represented by this Warrant in compliance with this Section 2, the Company will on the fifth Business Day following the date of receipt of the Exercise Notice, the Aggregate Exercise Price
and this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction), issue and surrender to a common carrier for overnight delivery to the address specified in the Exercise Notice, a
certificate, registered in the name of the Holder, for the number of shares of Common Stock to which the Holder will be entitled pursuant to such request. Upon delivery of the Exercise Notice and Aggregate Exercise Price, the Holder will be deemed
for all corporate purposes to have become the Holder of record of the Warrant Shares with respect to which this Warrant has been exercised. 

Notwithstanding any provisions in this Warrant to the contrary, if the fair market value of one Warrant Share is greater than the Exercise
Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, the Holder may elect to receive shares equal to the value (as determined below) of this Warrant (or the portion thereof being canceled) by
surrender of this Warrant at the principal office of the Company together with the properly endorsed Notice of Exercise in which event the Company will issue to the Holder a number of Warrant Shares computed using the following formula: 

 

									
		  		  	X =	  	 Y (A-B)
	  	
		  		  		  	A	  	
			
	 Where
	  	X =	  	the number of Warrant Shares to be issued to the Holder
			
		  	Y =	  	the number of Warrant Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, that portion of the Warrant being canceled (at the date of such calculation)
			
		  	A =	  	the fair market value of one Warrant Share (at the date of such calculation)
			
		  	B =	  	Exercise Price (as adjusted to the date of such calculation)

 For purposes of the above calculation, the fair market value of one Warrant Share will be determined by the
Company’s Board of Directors in good faith; provided, however, that in the event that this Warrant is exercised pursuant to this Section 2 in connection with the Company’s initial public offering of its Common
Stock, the fair market value per share will be the product of (i) the per share offering price to the public of the Company’s Common Stock in the initial public offering, and (ii) the number of shares of Common Stock into which each
Warrant Share is convertible at the time of such exercise. 

  
 3 

 (b) Unless the rights represented by this Warrant will have expired or will have been fully
exercised, the Company will, as soon as practicable and in no event later than five Business Days after any exercise and at its own expense, issue a new Warrant identical in all respects to this Warrant exercised except it will represent rights to
purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant exercised, less the number of Warrant Shares with respect to which such Warrant is exercised. 

(c) No fractional Warrant Shares are to be issued upon any pro rata exercise of this Warrant, but rather the number of Warrant Shares issued
upon such exercise of this Warrant will be rounded up or down to the nearest whole number. 
 (d) All Warrant Shares will be issued subject
to the terms of the Stockholders Agreement. The Company’s obligation to issue any Warrant Shares pursuant to the terms of this Warrant will be conditioned upon the Holder’s execution of the Stockholders Agreement. Any Warrant Shares issued
pursuant to this Warrant will bear such legends required by the terms of the Stockholders Agreement. 
 Section 3. Covenants.
The Company hereby covenants and agrees as follows: 
 (a) This Warrant is, and any Warrants issued in substitution for or replacement of
this Warrant will upon issuance be, duly authorized and validly issued. 
 (b) All Warrant Shares which may be issued upon the exercise of
the rights represented by this Warrant will, upon issuance, be validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof. 

(c) The Company will at all times have authorized and reserved at least one 100% of the number of shares of Common Stock needed to provide for
the exercise of the rights then represented by this Warrant and the par value of said shares will at all times be less than or equal to the applicable Warrant Exercise Price. If at any time the Company does not have a sufficient number of shares of
Common Stock authorized and available, then the Company will call and hold a special meeting of its stockholders within 60 days of that time for the sole purpose of increasing the number of authorized shares of Common Stock. 

(d) If at any time after the date hereof the Company will file a registration statement, the Company will include the shares of Common Stock
issuable upon conversion of the Common Shares issuable to the Holder, pursuant to the terms of this Warrant and will maintain, so long as any shares of its capital stock will be so listed, such listing of all shares of capital stock issuable upon
conversion of the Warrant Shares from time to time issuable upon the exercise of this Warrant; and the Company will so list on each national securities exchange or automated quotation system, as the case may be, and will maintain such listing of,
any other shares of capital stock of the Company issuable upon the exercise of this Warrant if and so long as any shares of the same class will be listed on such national securities exchange or automated quotation system. 

(e) The Company will not, by amendment of its certificate of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed by it hereunder, but will at all times in good faith assist in the
carrying out of all the provisions of this Warrant and in the taking of all such action as may reasonably be requested by the Holder of this Warrant in order to protect the exercise privilege of the Holder of this Warrant against dilution or other
impairment, consistent with the tenor and purpose of this Warrant. The 

  
 4 

 Company will not increase the par value of any shares of Common Stock receivable upon the exercise of this
Warrant above the Warrant Exercise Price then in effect, and (ii) will take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the
exercise of this Warrant. 
 (f) This Warrant will be binding upon any entity succeeding to the Company by merger, consolidation or
acquisition of all or substantially all of the Company’s assets. 
 Section 4. Taxes. The Company will pay all taxes (other
than taxes based upon income) and other governmental charges that may be imposed with respect to the issuance or delivery of shares of Common Stock upon exercise of this Warrant, other than any tax or other charge imposed in connection with any
transfer involved in the issue and delivery of shares of Common Stock in a name other than that of the Holder. 
 Section 5. Warrant
Holder Not Deemed a Stockholder. Except as otherwise specifically provided in this Warrant, no Holder, as such, of this Warrant will be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for
any purpose, nor will anything contained in this Warrant be construed to confer upon the Holder hereof, as such, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares
which he or she is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant will be construed as imposing any liabilities on such Holder to purchase any securities (upon exercise of this Warrant
or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 5, the Company will provide the Holder of this Warrant with copies of the
same notices and other information given to the other holders of Common Stock contemporaneously with the giving thereof to such holders. 

Section 6. Representations of Holder. The Holder of this Warrant, by the acceptance hereof, represents that it is acquiring this
Warrant and the Warrant Shares for its own account for investment only and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except pursuant to sales registered or
exempted under the Securities Act; provided, however, that by making the representations in this Warrant, the Holder does not agree to hold this Warrant or any of the Warrant Shares for any minimum or other specific term and reserves
the right to dispose of this Warrant and the Warrant Shares at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act and other applicable securities laws. The Holder of this Warrant further
represents, by acceptance of this Warrant, that, as of the Issuance Date, such Holder is an “accredited investor” as such term is defined in Rule 501(a)(1) of Regulation D promulgated by the Securities and Exchange Commission under the
Securities Act (an “Accredited Investor”). Upon exercise of this Warrant the Holder will, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the Warrant Shares so purchased are being
acquired solely for the Holder’s own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale and that such Holder is an Accredited Investor. If such Holder cannot make such
representations because they would be factually incorrect, it will be a condition to such Holder’s exercise of this Warrant that the Company receive such other representations as the Company considers reasonably necessary to assure the Company
that the issuance of its securities upon exercise of this Warrant will not violate any United States or state securities laws. 

  
 5 

 Section 7. Ownership and Transfer. 

(a) The Company will maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to the Holder hereof), a register for this Warrant, in which the Company will record the name and address of the person in whose name this Warrant has been issued, as well as the name and address of each transferee. The Company may treat the person
in whose name any Warrant is registered on the register as the owner and Holder thereof for all purposes, notwithstanding any notice to the contrary, but in all events recognizing any transfers made in accordance with the terms of this Warrant 

(b) The Company agrees that, notwithstanding anything to the contrary contained in this Warrant and subject only to compliance with applicable
federal and state securities laws, the Holder will be entitled to transfer all or any portion of this Warrant or of the Warrant Shares to an Affiliated Entity of the Holder. As used in this Section 7(b), an “Affiliated
Entity” of a Holder means any general or limited partner of such Holder, if such Holder is a partnership, any manager or member of such Holder, if such Holder is a limited liability company, or any person or entity that, directly or
indirectly, thorough one or more intermediaries, controls, is controlled by, or in under common control with, such Holder. The Holder agrees not to make any disposition of the Warrant or all or any portion of the Warrant Shares to an Affiliated
Entity or to any other Person unless and until (i) the Holder will have notified the Company of the proposed disposition and will have furnished the Company with a reasonably detailed statement of the circumstances surrounding the proposed
disposition and (ii) the transferee has agreed in writing for the benefit of the Company to be bound by the terms of this Warrant and any other stockholder or similar agreement among substantially all other holders of Common Stock as reasonably
requested by the Company, including, without limitation, the Stockholders Agreement. 
 (c) Except for transfers permitted under
Section 7(b), the Holder agrees not to make any disposition of the Warrant or all or any portion of the Warrant Shares or the shares issuable upon conversion thereof unless and until the transferee has agreed in writing for the benefit of
the Company to be bound by the terms of this Warrant and any other stockholder or similar agreement among substantially all other holders of Common Stock as reasonably requested by the Company, including, without limitation, the Stockholders
Agreement; and 
 (i) there is then in effect a registration statement under the Securities Act covering such proposed disposition and such
disposition is made in accordance with such registration statement; or 
 (ii) the Holder will have notified the Company of the proposed
disposition and will have furnished the Company with a reasonably detailed statement of the circumstances surrounding the proposed disposition, and if reasonably requested by the Company, the Holder will have furnished the Company with an opinion of
counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such shares under the Securities Act (it is agreed that the Company will not require opinions of counsel for transactions made pursuant to Rule
144 except in extraordinary circumstances). 
 Section 8. Adjustment of Warrant Exercise Price and Number of Shares. The Warrant
Exercise Price and the number of shares of Common Stock issuable upon exercise of this Warrant will be adjusted from time to time as follows: 

(a) Adjustment of Warrant Exercise Price upon Subdivision or Combination of Common Stock. If the Company at any time after the date of
issuance of this Warrant subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares 

  
 6 

 of Common Stock into a greater number of shares, any Warrant Exercise Price in effect immediately prior to such
subdivision will be proportionately reduced and the number of shares of Common Stock obtainable upon exercise of this Warrant will be proportionately increased. If the Company at any time after the date of issuance of this Warrant combines (by
combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, any Warrant Exercise Price in effect immediately prior to such combination will be proportionately
increased and the number of Warrant Shares issuable upon exercise of this Warrant will be proportionately decreased. Any adjustment under this Section 8(a) will become effective at the close of business on the date the subdivision or
combination becomes effective. 
 (b) Distribution of Assets. If the Company will declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin
off, reclassification, corporate rearrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case: 

(i) any Warrant Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders
of Common Stock entitled to receive the Distribution will be reduced, effective as of the close of business on such record date, to a price determined by multiplying such Warrant Exercise Price by a fraction of which (A) the numerator will be
the value of the Common Stock on the Business Day immediately preceding such record date minus the value of the Distribution (as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and
(B) the denominator will be the value of the Common Stock on the Business Day immediately preceding such record date. The value of the Common Stock for such purposes will be determined by an independent outside accountant selected by the Holder
and the Company; and 
 (ii) either (A) the number of Warrant Shares obtainable upon exercise of this Warrant will be increased to a
number of shares equal to the number of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the determination of holders of Common Stock entitled to receive the Distribution multiplied by the
reciprocal of the fraction set forth in the immediately preceding clause (i), or (B) in the event that the Distribution is of common stock of a company whose common stock is traded on a national securities exchange or a national automated
quotation system, then the Holder of this Warrant will receive an additional warrant to purchase Common Stock, the terms of which will be identical to those of this Warrant, except that such warrant will be exercisable into the amount of the assets
that would have been payable to the Holder of this Warrant pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record date and with an exercise price equal to the amount by which the exercise price of this
Warrant was decreased with respect to the Distribution pursuant to the terms of the immediately preceding clause (i). 
 (c) Definition
of shares of Common Stock. For the purposes of this Section 8, the term “shares of Common Stock” will mean (i) the class of stock designated as the Common Stock of the Company on the Issuance Date or (ii) any
other class of stock resulting from changes or reclassifications of such shares consisting solely of changes in par value, or from par value to no par value, or from no par value to par value. In the event that at any time, as a result of an
adjustment made pursuant to Section 8(b), the Holders will become entitled to purchase any shares of the Company other than shares of Common Stock, thereafter the number of such other shares so purchasable upon exercise of each Warrant
and the Warrant Exercise Price of such shares will be subject to adjustment from time to 

  
 7 

 time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the Warrant
Shares contained in Section 8 as they would have been applied to the Warrant Shares. 
 (d) Minimum adjustment. No
adjustment in the number of shares purchasable hereunder will be required unless such adjustment would require an increase or decrease of at least one half (1/2) of one percent (1%) in the number of shares purchasable upon the exercise of
each Warrant; provided, however, that any adjustments which by reason of this Section 8(f) are not required to be made will be carried forward and taken into account in any subsequent adjustment or upon any exercise of a Warrant. 

(e) Certain Events. If any event occurs of the type contemplated by the provisions of this Section 8 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features, in each case, that relate to the Common Stock), then the Company’s Board of Directors
will make an appropriate adjustment in the Warrant Exercise Price and the number of shares of Common Stock obtainable upon exercise of this Warrant so as to protect the rights of the Holders of the Warrants; provided that no such adjustment pursuant
to this Section 8(e) will increase the Warrant Exercise Price or decrease the number of shares of Common Stock obtainable as otherwise determined pursuant to this Section 8. 

(f) Notices. 
 (i)
Immediately upon any adjustment of the Warrant Exercise Price, the Company will give written notice thereof to the Holder of this Warrant, setting forth in reasonable detail, and certifying, the calculation of such adjustment. 

(ii) The Company will give written notice to the Holder of this Warrant at least ten days prior to the date on which the Company closes its
books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B) with respect to any pro rata subscription offer to Holders of Common Stock or (C) for determining rights to vote with respect to any
Organic Change (as defined below), dissolution or liquidation, provided that such information will be made known to the public prior to or in conjunction with such notice being provided to such Holder. 

(iii) The Company will also give written notice to the Holder of this Warrant at least ten days prior to the date on which any Organic
Change, dissolution or liquidation will take place, provided that such information will be made known to the public prior to or in conjunction with such notice being provided to such Holder. 

Section 9. Purchase Rights; Reorganization, Reclassification, Consolidation, Merger or Sale. 

(a) Any recapitalization, reorganization, reclassification, consolidation, merger, sale of all or substantially all of the Company’s
assets to another Person or other transaction in each case which is effected in such a way that Holders of Common Stock are entitled to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in
exchange for Common Stock is referred to in this Warrant as an “Organic Change.” Prior to the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other
Organic Change following which the Company is not a surviving entity, the Company will secure from the Person purchasing such assets or the successor resulting from such Organic Change (in each case, the “Acquiring Entity”) a
written agreement (in form and substance reasonably satisfactory to the Holder) to deliver to each Holder of Warrants in exchange for such Warrants, a security of the Acquiring Entity evidenced by a 

  
 8 

 written instrument substantially similar in form and substance to this Warrant and reasonably satisfactory to the
Holders of the Warrants (including an adjusted warrant exercise price equal to the value for the Common Stock reflected by the terms of such consolidation, merger or sale, and exercisable for a corresponding number of shares of Common Stock
acquirable and receivable upon exercise of the Warrants without regard to any limitations on exercise, if the value so reflected is less than any Applicable Warrant Exercise Price immediately prior to such consolidation, merger or sale).
Notwithstanding the previous sentence of this Subsection (b), in the event as of the date of the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other Organic Change
following which the Company is not a surviving entity, the fair market value of the Warrant Shares, as determined by the Company’s Board of Directors in good faith, is greater than three times the then Warrant Exercise Price and the Holder is
given the right to exercise the Warrants prior to or concurrently with such consummation, the Acquiring Entity may elect not to deliver to each Holder of Warrants in exchange for such Warrants, a security of the Acquiring Entity and each Holder will
be required to exercise the Warrants in connection with such transaction. Prior to the consummation of any other Organic Change, the Company will make appropriate provision (in form and substance reasonably satisfactory to the Holder) to insure that
the Holder will thereafter have the right to acquire and receive in lieu of or in addition to (as the case may be) the Warrant Shares immediately theretofore issuable and receivable upon the exercise of such Holder’s Warrants without regard to
any limitations on exercise), such shares of stock, securities or assets that would have been issued or payable in such Organic Change with respect to or in exchange for the number of Warrant Shares which would have been issuable and receivable upon
the exercise of such Holder’s Warrant as of the date of such Organic Change (without taking into account any limitations or restrictions on the exercisability of this Warrant). 

Section 10. Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will promptly, on
receipt of an indemnification undertaking (or, in the case of a mutilated Warrant, the Warrant), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed. 

Section 11. Notice. Any notices, consents, waivers or other communications required or permitted to be given under the terms of
this Warrant must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of receipt is received by the sending party
transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to
receive the same. The addresses and facsimile numbers for such communications will be: 
  

					
	If to Holder:	 	Trinity SynCardia Bridge, LLC
		 	3195 West Ray Road, #9
		 	Chandler, Arizona 85226
		 	Telephone:	  	480-374-3551
		 	Facsimile:	  	480-247-5099
		 	Attention:	  	TR Management, LLC, Manager
		
	With Copy to:	 	Hool Law Group, PLC
		 	2398 East Camelback Road
		 	Suite 1020
		 	Phoenix, Arizona 85016
		 	Telephone:	  	602-852-5560
		 	Facsimile:	  	602-852-5499
		 	Attention:	  	Michael D. Hool, Esq.

  
 9 

					
	If to the Company, to:	 	SynCardia Systems, Inc.
		 	1992 East Silverlake Road
		 	Tucson, Arizona 85713
		 	Attention:	  	Michael Garippa
		 	Telephone:	  	520-545-1234
		 	Facsimile:	  	520-903-1782
		
	With a copy to:	 	James W. Zeeb
		 	405 West Franklin
		 	Tucson, Arizona 85701
		 	Telephone:	  	520-798-3803
		 	Facsimile:	  	520-620-0405

 Each party will provide five days’ prior written notice to the other party of any change in address or facsimile number.
Written confirmation of receipt (A) given by the recipient of such notice, consent, facsimile, waiver or other communication, or (B) provided by a nationally recognized overnight delivery service will be rebuttable evidence of personal
service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively. 

Section 12. Amendment and Waiver. Except as otherwise provided in this Warrant, the provisions of the Warrants may be amended and
the Company may take any action in this Warrant prohibited, or omit to perform any act in this Warrant required to be performed by it, only if the Company has obtained the written consent of the Requisite Holders; provided, however, that, except for
Sections 8(a) and 8(d), no such action may increase the Warrant Exercise Price or decrease the number of shares or class of stock obtainable upon exercise of any Warrant without the written consent of the Holder of such Warrant. 

Section 13. Descriptive Headings; Governing Law. The descriptive headings of the several sections and paragraphs of this Warrant
are inserted for convenience only and do not constitute a part of this Warrant. All questions concerning the construction, validity, enforcement and interpretation of this Agreement will be governed by the internal laws of the State of Arizona,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Arizona or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Arizona. Each
party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in Arizona, for the adjudication of any dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby or
discussed in this Warrant, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
thereof to such party at the address for such notices to it under this Agreement and agrees that such service will constitute good and sufficient service of process and notice thereof. Nothing contained in this Warrant will be deemed to limit in any
way any right to serve process in any manner permitted by law. 

  
 10 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as of the date first
set forth above. 
  

			
	SYNCARDIA SYSTEMS, INC., a Delaware corporation
		
	By:	 	/s/ Michael Garippa
	Name:	 	Michael Garippa
	Title:	 	CEO and President

  
 11 

 EXHIBIT A TO WARRANT 

EXERCISE NOTICE 

TO BE EXECUTED 
 BY THE
REGISTERED HOLDER TO EXERCISE THIS WARRANT 
  

 
 The undersigned
Holder hereby exercises the right to purchase                  of the shares of Common Stock (“Warrant Shares”) of SynCardia Systems, Inc., a Delaware
corporation (the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”). Capitalized terms used in this Warrant and not otherwise defined will have the respective meanings set forth
in the Warrant. 
 1. Form of Warrant Exercise Price. The Holder intends that payment of the Warrant Exercise Price will be made as a
“Cash Exercise” with respect to                  Warrant Shares. 

2. Payment of Warrant Exercise Price. The Holder will pay the sum of $         to the Company
in accordance with the terms of the Warrant. 
 3. Delivery of Warrant Shares. The Company will deliver to the Holder
                 Warrant Shares in accordance with the terms of the Warrant. 

Date:             ,          

 

			
	TRINITY SYNCARDIA BRIDGE, LLC, an Arizona limited liability company
	
	 TR Management, LLC, an Arizona limited         liability company, as Manager

		
	        By:	 	  

		 	Tim Wolf, Manager

  
 A-1 

 EXHIBIT B TO WARRANT 

FORM OF WARRANT POWER 

FOR VALUE RECEIVED, the undersigned does hereby assign and transfer to
                , Federal Identification No.                     , a
warrant to purchase                  shares of the Common Stock of SynCardia Systems, Inc., a Delaware corporation, represented by warrant certificate no.
            , standing in the name of the undersigned on the books of said corporation. The undersigned does hereby irrevocably constitute and appoint
                    , attorney to transfer the warrants of said corporation, with full power of substitution in the premises. 

Dated:             , 20     

 

			
	TRINITY SYNCARDIA BRIDGE, LLC, an Arizona limited liability company
	
	 TR Management, LLC, an Arizona limited         liability company, as Manager

		
	        By:	 	  

		 	Tim Wolf, Manager

  
 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]